{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:20:37Z","timestamp":1788175237937,"version":"build-2803163510"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_dx-2025-0144_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>It is important to review laboratory test panels regularly and omit unnecessary tests. This avoids overdiagnosis and makes laboratory work more targeted. Artificial intelligence is increasingly being discussed as a possible aid in such decisions. The aim of the study was to revise an existing thrombophilia panel with the help of a modified Delphi consensus of laboratory physicians and to examine whether large language models (LLMs) can mimic such decision-making processes and serve as a support\u00a0tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dx-2025-0144_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study was conducted in two steps. First, six experts evaluated various thrombophilia parameters in three Delphi rounds, assessing technical reliability and clinical significance. Selected LLMs (Elicit, Consensus, and STORM) were then tested with questions. Their results were compared with the Delphi consensus. Agreement was calculated using percentage concordance and Cohen\u2019s \u03ba.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dx-2025-0144_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PAI-1 genotyping,\n                      <jats:italic>MTHFR<\/jats:italic>\n                      genotyping, homocysteine and APC resistance were removed from the standard panel, and anti-annexin-V antibodies and anti-phosphatidylserine\/prothrombin antibodies were completely eliminated. The reduced panel was incorporated into routine practice, with facultative parameters remaining available as second-line tests. Agreement between the LLMs and the experts was slight when using open prompts (\u03ba \u2248 0.25), although, with specific questions, the agreement was higher (\u03ba 0.50\u20130.52). However, the LLMs did not take into account analytical and technical aspects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dx-2025-0144_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Thrombophilia panels should be reviewed regularly to avoid the application of unnecessary tests and ensure high diagnostic quality. The Delphi process is a suitable tool for this. LLMs can provide supporting information, but are currently no substitute for the experience and consensus of medical experts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/dx-2025-0144","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:55:41Z","timestamp":1768197341000},"page":"475-484","source":"Crossref","is-referenced-by-count":0,"title":["Rationalisation of a thrombophilia panel using laboratory medicine Delphi-like consensus evaluation and secondary artificial intelligence-based simulation assessment"],"prefix":"10.1515","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5242-4660","authenticated-orcid":false,"given":"Bernhard","family":"Strasser","sequence":"first","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine , Klinikum Wels-Grieskirchen , Wels , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine , Klinikum Wels-Grieskirchen , Wels , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Wimmer","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine , Klinikum Wels-Grieskirchen , Wels , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Seier","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine , Klinikum Wels-Grieskirchen , Wels , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"2026083110583439014_j_dx-2025-0144_ref_001","doi-asserted-by":"crossref","unstructured":"Moore, GW. Thrombophilia screening: not so straightforward. Semin Thromb Hemost 2024;50:1131\u201352. https:\/\/doi.org\/10.1055\/s-0044-1786807.","DOI":"10.1055\/s-0044-1786807"},{"key":"2026083110583439014_j_dx-2025-0144_ref_002","doi-asserted-by":"crossref","unstructured":"Middeldorp, S, Nieuwlaat, R, Baumann Kreuziger, L, Coppens, M, Houghton, D, James, AH, et al.. American society of hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv 2023;7:7101\u201338. https:\/\/doi.org\/10.1182\/bloodadvances.2023010177.","DOI":"10.1182\/bloodadvances.2023010177"},{"key":"2026083110583439014_j_dx-2025-0144_ref_003","doi-asserted-by":"crossref","unstructured":"Middeldorp, S, Iorio, A. Thrombophilia testing: does practice follow guidelines? Blood Adv 2024;8:4948\u20139. https:\/\/doi.org\/10.1182\/bloodadvances.2024013478.","DOI":"10.1182\/bloodadvances.2024013478"},{"key":"2026083110583439014_j_dx-2025-0144_ref_004","doi-asserted-by":"crossref","unstructured":"Ashraf, N, Visweshwar, N, Jaglal, M, Sokol, L, Laber, D. Evolving paradigm in thrombophilia screening. Blood Coagul Fibrinolysis 2019;30:249\u201352. https:\/\/doi.org\/10.1097\/mbc.0000000000000809.","DOI":"10.1097\/MBC.0000000000000809"},{"key":"2026083110583439014_j_dx-2025-0144_ref_005","doi-asserted-by":"crossref","unstructured":"Wang, J, Wang, C, Chen, N, Shu, C, Guo, X, He, Y, et al.. Association between the plasminogen activator inhibitor-1 4G\/5G polymorphism and risk of venous thromboembolism: a meta-analysis. Thromb Res 2014;134:1241\u20138. https:\/\/doi.org\/10.1016\/j.thromres.2014.09.035.","DOI":"10.1016\/j.thromres.2014.09.035"},{"key":"2026083110583439014_j_dx-2025-0144_ref_006","doi-asserted-by":"crossref","unstructured":"Moll, S, Varga, EA. Homocysteine and MTHFR mutations. Circulation 2015;132:e6\u20139. https:\/\/doi.org\/10.1161\/circulationaha.114.013311.","DOI":"10.1161\/CIRCULATIONAHA.114.013311"},{"key":"2026083110583439014_j_dx-2025-0144_ref_007","doi-asserted-by":"crossref","unstructured":"Zeng, J, Zeng, Q. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: a meta-analysis of 99 genetic association studies. Eur J Prev Cardiol 2019;26:120\u201334. https:\/\/doi.org\/10.1177\/2047487318799467.","DOI":"10.1177\/2047487318799467"},{"key":"2026083110583439014_j_dx-2025-0144_ref_008","doi-asserted-by":"crossref","unstructured":"Arnold, J, Holmes, Z, Pickering, W, Farmer, C, Regan, L, Cohen, H. Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 2001;113:911\u20134. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02812.x.","DOI":"10.1046\/j.1365-2141.2001.02812.x"},{"key":"2026083110583439014_j_dx-2025-0144_ref_009","doi-asserted-by":"crossref","unstructured":"Tonello, M, Bison, E, Cattini, MG, Pontara, E, Iaccarino, L, Denas, G, et al.. Anti-Phosphatidyl-Serine\/prothrombin antibodies (aPS\/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity? Clin Chem Lab Med 2021;59:1950\u20133. https:\/\/doi.org\/10.1515\/cclm-2021-0692.","DOI":"10.1515\/cclm-2021-0692"},{"key":"2026083110583439014_j_dx-2025-0144_ref_010","doi-asserted-by":"crossref","unstructured":"Hoffer, EP, James, CA, Wong, A, Ranji, S. Artificial intelligence and medical diagnosis: past, present and future. Diagnosis. 2025;12:564\u20139. https:\/\/doi.org\/10.1515\/dx-2025-0111.","DOI":"10.1515\/dx-2025-0111"},{"key":"2026083110583439014_j_dx-2025-0144_ref_011","doi-asserted-by":"crossref","unstructured":"Bridges, JM. Computerized diagnostic decision support systems\u00a0\u2013\u00a0a comparative performance study of Isabel Pro vs. ChatGPT4. Diagnosis (Berl) 2024;11:250\u20138. https:\/\/doi.org\/10.1515\/dx-2024-0033.","DOI":"10.1515\/dx-2024-0033"},{"key":"2026083110583439014_j_dx-2025-0144_ref_012","doi-asserted-by":"crossref","unstructured":"Lippi, G, Jackson, B, Plebani, M. Improving diagnosis in health care: laboratory medicine. Diagnosis 2025;12:570\u20137. https:\/\/doi.org\/10.1515\/dx-2025-0052.","DOI":"10.1515\/dx-2025-0052"},{"key":"2026083110583439014_j_dx-2025-0144_ref_013","doi-asserted-by":"crossref","unstructured":"Ambasta, A, Holroyd-Leduc, JM, Pokharel, S, Mathura, P, Shih, AW, Stelfox, HT, et al.. Re-Purposing the ordering of routine laboratory tests in hospitalized medical patients (RePORT): protocol for a multicenter stepped-wedge cluster randomised trial to evaluate the impact of a multicomponent intervention bundle to reduce laboratory test over-utilization. Implement Sci 2024;19:45. https:\/\/doi.org\/10.1186\/s13012-024-01376-6.","DOI":"10.1186\/s13012-024-01376-6"},{"key":"2026083110583439014_j_dx-2025-0144_ref_014","doi-asserted-by":"crossref","unstructured":"Dube, K, Wu, B. Supporting clinical laboratory test-ordering protocol specification, execution and management: an event-condition-action rule and database approach. Health Inf J 2001;7:20\u20138. https:\/\/doi.org\/10.1177\/146045820100700105.","DOI":"10.1177\/146045820100700105"},{"key":"2026083110583439014_j_dx-2025-0144_ref_015","doi-asserted-by":"crossref","unstructured":"Plebani, M, Cadamuro, J, Vermeersch, P, Jovicic, S, Ozben, T, Trenti, T, et al.. A vision to the future: value-based laboratory medicine. Clin Chem Lab Med 2024;62:2373\u201387. https:\/\/doi.org\/10.1515\/cclm-2024-1022.","DOI":"10.1515\/cclm-2024-1022"},{"key":"2026083110583439014_j_dx-2025-0144_ref_016","doi-asserted-by":"crossref","unstructured":"Salinas, M, Torreblanca, R, Sanchez, E, Blasco, A, Flores, E, Lopez-Garrigos, M. Managing laboratory test ordering: a challenge in the new laboratory medicine model. Adv Lab Med 2024;5:236\u201347. https:\/\/doi.org\/10.1515\/almed-2024-0085.","DOI":"10.1515\/almed-2024-0085"},{"key":"2026083110583439014_j_dx-2025-0144_ref_017","unstructured":"Hanly, JG, Smith, SA, Anderson, D. Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis. J\u00a0Rheumatol 2003;30:1990\u20133."},{"key":"2026083110583439014_j_dx-2025-0144_ref_018","doi-asserted-by":"crossref","unstructured":"Varga, EA, Sturm, AC, Misita, CP, Moll, S. Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 2005;111:e289\u201393. https:\/\/doi.org\/10.1161\/01.CIR.0000165142.37711.E7.","DOI":"10.1161\/01.CIR.0000165142.37711.E7"},{"key":"2026083110583439014_j_dx-2025-0144_ref_019","doi-asserted-by":"crossref","unstructured":"Simone, B, De Stefano, V, Leoncini, E, Zacho, J, Martinelli, I, Emmerich, J, et al.. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, Prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 2013;28:621\u201347. https:\/\/doi.org\/10.1007\/s10654-013-9825-8.","DOI":"10.1007\/s10654-013-9825-8"},{"key":"2026083110583439014_j_dx-2025-0144_ref_020","doi-asserted-by":"crossref","unstructured":"Di Minno, MN, Tremoli, E, Coppola, A, Lupoli, R, Di Minno, G. Homocysteine and arterial thrombosis: challenge and opportunity. Thromb Haemost 2010;103:942\u201361. https:\/\/doi.org\/10.1160\/th09-06-0393.","DOI":"10.1160\/TH09-06-0393"},{"key":"2026083110583439014_j_dx-2025-0144_ref_021","doi-asserted-by":"crossref","unstructured":"Chiasakul, T, Bauer, KA. The dos, don\u2019ts, and nuances of thrombophilia testing. Hematology Am Soc Hematol Educ Program 2023;2023:593\u20139. https:\/\/doi.org\/10.1182\/hematology.2023000491.","DOI":"10.1182\/hematology.2023000491"},{"key":"2026083110583439014_j_dx-2025-0144_ref_022","doi-asserted-by":"crossref","unstructured":"Huang, G, Wang, P, Li, T, Deng, X. Genetic association between plasminogen activator inhibitor-1 rs1799889 polymorphism and venous thromboembolism: evidence from a comprehensive meta-analysis. Clin Cardiol 2019;42:1232\u20138. https:\/\/doi.org\/10.1002\/clc.23282.","DOI":"10.1002\/clc.23282"},{"key":"2026083110583439014_j_dx-2025-0144_ref_023","doi-asserted-by":"crossref","unstructured":"Herskovits, AZ, Morgan, EA, Lemire, SJ, Lindeman, NI, Dorfman, DM. An improved algorithm for activated protein C resistance and factor V Leiden screening. Am J Clin Pathol 2013;140:379\u201386. https:\/\/doi.org\/10.1309\/ajcpo6vup3mzeywu.","DOI":"10.1309\/AJCPO6VUP3MZEYWU"},{"key":"2026083110583439014_j_dx-2025-0144_ref_024","doi-asserted-by":"crossref","unstructured":"Favaloro, EJ, Arunachalam, S, Dean, E, Salwa, M, Ahuja, M, Connelly, L, et al.. Activated protein C resistance testing: an update from Australasia\/Asia-Pacific. Int J Lab Hematol 2025;47:720\u20139. https:\/\/doi.org\/10.1111\/ijlh.14447.","DOI":"10.1111\/ijlh.14447"},{"key":"2026083110583439014_j_dx-2025-0144_ref_025","doi-asserted-by":"crossref","unstructured":"Rodeghiero, F, Tosetto, A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999;130:643\u201350. https:\/\/doi.org\/10.7326\/0003-4819-130-8-199904200-00004.","DOI":"10.7326\/0003-4819-130-8-199904200-00004"},{"key":"2026083110583439014_j_dx-2025-0144_ref_026","doi-asserted-by":"crossref","unstructured":"Tripodi, A, Chantarangkul, V, Martinelli, I, Bucciarelli, P, Mannucci, PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004;104:3631\u20134. https:\/\/doi.org\/10.1182\/blood-2004-03-1042.","DOI":"10.1182\/blood-2004-03-1042"},{"key":"2026083110583439014_j_dx-2025-0144_ref_027","doi-asserted-by":"crossref","unstructured":"Siriez, R, Dogne, JM, Gosselin, R, Laloy, J, Mullier, F, Douxfils, J. Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: practical recommendations for the laboratory. Int J Lab Hematol 2021;43:7\u201320. https:\/\/doi.org\/10.1111\/ijlh.13342.","DOI":"10.1111\/ijlh.13342"},{"key":"2026083110583439014_j_dx-2025-0144_ref_028","doi-asserted-by":"crossref","unstructured":"Carobene, A, Cadamuro, J, Frans, G, Goldshmidt, H, Debeljak, Z, Bruyne, SD, et al.. EFLM checklist for the assessment of AI\/ML studies in laboratory medicine: enhancing general medical AI frameworks for laboratory-specific applications. Clin Chem Lab Med 2026;64:27\u201340. https:\/\/doi.org\/10.1515\/cclm-2025-0841.","DOI":"10.1515\/cclm-2025-0841"},{"key":"2026083110583439014_j_dx-2025-0144_ref_029","doi-asserted-by":"crossref","unstructured":"Trulson, I, Holdenrieder, S, Hoffmann, G. Using machine learning techniques for exploration and classification of laboratory data. J\u00a0Lab Med 2024;48:203\u201314. https:\/\/doi.org\/10.1515\/labmed-2024-0100.","DOI":"10.1515\/labmed-2024-0100"},{"key":"2026083110583439014_j_dx-2025-0144_ref_030","doi-asserted-by":"crossref","unstructured":"Yesil, MR, Talli, I, Pelloso, M, Cosma, C, Pangrazzi, E, Plebani, M, et al.. Impact of analytical bias on machine learning models for sepsis prediction using laboratory data. Clin Chem Lab Med 2025;63:2022\u201330. https:\/\/doi.org\/10.1515\/cclm-2025-0491.","DOI":"10.1515\/cclm-2025-0491"},{"key":"2026083110583439014_j_dx-2025-0144_ref_031","doi-asserted-by":"crossref","unstructured":"Niu, Z, Kuang, X, Chen, J, Cai, X, Zhang, P. The application and challenges of ChatGPT in laboratory medicine. Adv Lab Med\/Avances en Medicina de Laboratorio 2025;6:385\u201396. https:\/\/doi.org\/10.1515\/almed-2025-0080.","DOI":"10.1515\/almed-2025-0080"},{"key":"2026083110583439014_j_dx-2025-0144_ref_032","doi-asserted-by":"crossref","unstructured":"Sele, D, Chugunova, M. Putting a human in the loop: increasing uptake, but decreasing accuracy of automated decision-making. PLoS One 2024;19:e0298037. https:\/\/doi.org\/10.1371\/journal.pone.0298037.","DOI":"10.1371\/journal.pone.0298037"}],"container-title":["Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dx-2025-0144\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dx-2025-0144\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:59:06Z","timestamp":1788173946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dx-2025-0144\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,2]]},"published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.1515\/dx-2025-0144"],"URL":"https:\/\/doi.org\/10.1515\/dx-2025-0144","relation":{},"ISSN":["2194-8011","2194-802X"],"issn-type":[{"value":"2194-8011","type":"print"},{"value":"2194-802X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}